In part 3 of our interview with John C. Goodman, PhD, he discusses how TrumpRx could impact the drug supply chain—specifically PBMs.
Total Pharmacy
Latest News
Total Pharmacy Podcasts
All News
Advertisement
Independent pharmacies face significant challenges—such as software limitations, staffing shortages, and inconsistent billing requirements—that hinder fair reimbursement for clinical services.
John C. Goodman, PhD, discusses TrumpRx’s impact on patients and pharmacies, comparing this administration’s approach with the previous Biden Administration.
John C. Goodman, PhD, senior fellow at the Independent Institute, discusses TrumpRx and its goals for patients’ OOP drug costs.
Community pharmacies are facing major barriers due to PBM practices and vertical integration, ultimately jeopardizing patient access and trust in health care.
In this episode, host Taylor Watterson, PharmD, PhD, welcomes Wesley Sparkmon, PhD, MPH, assistant professor of pharmacy sciences at Creighton University.
Experts at the Milken Institute address better ways of adopting pharmacy services within the greater health care ecosystem.
A conversation with NCPDP’s Rick Sage explored the lasting effects on pharmacy stemming from the record-breaking government shutdown.
Rick Sage, executive vice president of innovation and standards with the NCPDP, discusses the nuances of billing under either Medicare Part B or D.
This episode explores ongoing developments in pharmacy law, specifically for independent pharmacies and their representatives who attended the 2025 NCPA Convention & Expo.
Advertisement
This collaboration is designed to bring resources addressing pharmacy shortages to the fingertips of the general public.
The event will explore the importance of advocacy, gathering experts all across community pharmacy to discuss improving patient access and education.
With a new year approaching, pharmacy law experts joined Over the Counter to recap some of the key events regarding state- and federal-level PBM reform throughout 2025.
This episode explores the complex composition of a good leader within the pharmacy industry.
Through diabetes education and initiatives focused on community health care, Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, is making a difference for patients and the pharmacy profession.
Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, discusses the Touro University California, pharmacist-led Pharm2Home initiative.
Lisa Schwartz, PharmD, discusses her general opinions regarding how the predicted success of the Medicare Drug Price Negotiation Program’s future implementation.
Lisa Schwartz, PharmD, discusses community pharmacies’ displeasure with provisions backing the Medicare Drug Price Negotiation Program.
Lisa Schwartz, PharmD, discusses the importance of the Medicare Transaction Facilitator as community pharmacies head into a new year of the Medicare Drug Price Negotiation Program.
The final part of our interview with Dae Lee, PharmD, Esq, CPBS, and Lucas Morgan, Esq, focuses on the relationships between state- and federal-level PBM reform.
From the COVID-19 pandemic through state-by-state expansion of scope, pharmacists have tapped into a variety of their clinical skills to bolster patient outcomes in their communities.
In part 4 of our interview with Jennifer Griffin, PharmD, MS, she discusses different payer engagement models and the pharmacists’ ability to understand and improve medical billing tactics.
At the NCPA 2025 Annual Convention & Expo, Lucas Morgan, Esq, shareholder with Buchanan Ingersoll & Rooney, joined us to discuss ongoing PBM legislation in the state of Arkansas.
Alyssa Mack, PharmD, pharmacist at Gibbs Pharmacy and Compounding Center, discusses how expanding clinical services can simultaneously benefit patients and the pharmacy profession.
Tara Pfund, PharmD, chief strategy officer with Cascadia Pharmacy Group, discusses the importance of pharmacy businesses to understand evolving and emerging health care technology.
Jennifer Griffin, PharmD, MS, clinical pharmacist at Harps Food Stores, Inc, discusses revenue cycle management and how it has developed within community pharmacy.
Advertisement
Advertisement
Trending on Drug Topics
1
Trump Administration Looking to Bypass PBMs Through Online DTC Pharmacy
2
ACIP Vote Eliminates Universal Recommendation for Newborn Hepatitis B Vaccine
3
Pharmacists Remain Health Care Focal Point as Vaccine Recommendations Change
4
Pharmacists Now Authorized to Independently Prescribe Buprenorphine
5
